Pfizer’s $25 Million Equity Investment in Zentalis Pharmaceuticals

Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

DigitalBridge’s €745 Million Acquisition of Telenet’s Mobile Telecommunication Tower Business

Latham & Watkins represented DigitalBridge in the transaction. DigitalBridge Group, Inc. (NYSE: DBRG) has announced its affiliate, DigitalBridge Investment LLC (“DigitalBridge”), has entered into an agreement...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

EngageSmart’s $378 Million IPO

Latham & Watkins represented EngageSmart, while Fenwick & West advised the underwriters on the deal. EngageSmart (NYSE: ESMT) announced its initial public offering. The company is a leading...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here